Maryland State Retirement & Pension System’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Maryland State Retirement & Pension System’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,585	Closed	-$204K	–	1433
2022 Q2	$204K	Hold	4,585	–	–	0.01%	1431
2022 Q1	$227K	Hold	4,585	–	–	0.01%	1432
2021 Q4	$233K	Hold	4,585	–	–	0.01%	1452
2021 Q3	$255K	Buy	+4,585	New	+$226K	0.01%	1432

Other funds holding EGRX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Maryland State Retirement & Pension System's EGRX Position: Q3 2022 in Review

Maryland State Retirement & Pension System sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2022, closing a stake of 4,585 shares — an estimated $204K sold.

Maryland State Retirement & Pension System first reported a position in EGRX in Q3 2021 and held it in 4 quarters. The position peaked at $255K in Q3 2021. 153 funds tracked by Wall St. Rank hold EGRX as of Q3 2022.

Maryland State Retirement & Pension System reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
Maryland State Retirement & Pension System sold 4,585 Eagle Pharmaceuticals, Inc. shares in Q3 2022, an estimated $204K.
Maryland State Retirement & Pension System first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2021 and held it in 4 quarters.
Maryland State Retirement & Pension System's Eagle Pharmaceuticals, Inc. position peaked at $255K in Q3 2021.
153 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2022.

Based on Maryland State Retirement & Pension System's 13F filing for Q3 2022, filed 28 Oct 2022.